Lucas and Luna explore how quantum computers are beginning to simulate enzyme reactions, a task classical computers struggle with due to the quantum nature of chemical bonds. They focus on a 2025 landmark study from IBM and pharmaceutical company Roche that used a 127-qubit system to model the active site of cytochrome P450, an enzyme responsible for metabolizing half of all drugs. The episode explains why this matters: if quantum simulations can accurately predict how new drugs interact with enzymes, it could slash the $2.6 billion average cost of bringing a drug to market and reduce the need for animal testing. Lucas breaks down the technical leap: earlier simulations could only handle tiny molecules like hydrogen, but the P450 simulation involved 4,000 atoms. Luna pushes back on hype, asking about error rates and scalability. The hosts also discuss the practical timeline — why this breakthrough is more about proof of concept than immediate industry adoption. A concrete look at what quantum chemistry can actually do today.

#QuantumComputing #DrugDiscovery #EnzymeSimulation #CytochromeP450 #IBM #Roche #QuantumChemistry #Pharmaceuticals #DrugDevelopment #MolecularSimulation #QuantumHardware #Technology #FexingoBusiness #BusinessPodcast #QuantumPodcast #TechPodcast #FutureOfMedicine #ComputationalChemistry

Keep every episode free: buymeacoffee.com/fexingo